Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 4
2009 4
2010 1
2011 1
2012 4
2013 2
2014 8
2015 3
2016 7
2017 4
2018 3
2019 3
2020 4
2021 9
2022 6
2023 7
2024 3
2025 9
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
Prognostic and predictive factors for the efficacy and safety of trastuzumab deruxtecan in HER2-positive gastric or gastroesophageal junction cancer.
Jubashi A, Nakayama I, Koganemaru S, Sakamoto N, Oda S, Matsubara Y, Miyashita Y, Sato S, Ushiyama S, Kobayashi A, Okazaki U, Okemoto D, Yamamoto K, Mishima S, Kotani D, Kawazoe A, Hashimoto T, Nakamura Y, Kuboki Y, Bando H, Kojima T, Yoshino T, Miyaaki H, Nakao K, Shitara K. Jubashi A, et al. Among authors: sato s. Gastric Cancer. 2025 Jan;28(1):63-73. doi: 10.1007/s10120-024-01560-z. Epub 2024 Nov 2. Gastric Cancer. 2025. PMID: 39487862 Free PMC article.
Prognostic Indicators of Preoperative Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel Efficacy in Locally Advanced Gastroesophageal and Gastric Cancer: Integrating Biomarker Analysis and Clinicopathological Factors.
Jubashi A, Nakayama I, Sakamoto N, Takei S, Matsubara Y, Miyashita Y, Sato S, Ushiyama S, Kobayashi A, Okazaki U, Okemoto D, Yamamoto K, Mishima S, Kotani D, Kawazoe A, Hashimoto T, Nakamura Y, Kuboki Y, Bando H, Kojima T, Yoshino T, Kuwata T, Sato K, Fujita T, Yoshida M, Yura M, Kinoshita T, Shitara K. Jubashi A, et al. Among authors: sato s. JCO Precis Oncol. 2025 Aug;9:e2400925. doi: 10.1200/PO-24-00925. Epub 2025 Aug 1. JCO Precis Oncol. 2025. PMID: 40749150 Free PMC article.
Impact of claudin 18.2 expression on treatment outcomes of first-line immunochemotherapy in patients with HER2-negative, proficient MMR, PD-L1 CPS ⩾1 metastatic gastric/gastroesophageal junction cancer.
Zhang F, Nakayama I, Sakamoto N, Okemoto D, Jubashi A, Matsubara Y, Miyashita Y, Sato S, Ushiyama S, Kobayashi A, Okazaki U, Yamamoto K, Mishima S, Kotani D, Kawazoe A, Hashimoto T, Nakamura Y, Kuboki Y, Bando H, Kojima T, Yoshino T, Kuwata T, Shitara K. Zhang F, et al. Among authors: sato s. Ther Adv Med Oncol. 2025 Sep 20;17:17588359251369042. doi: 10.1177/17588359251369042. eCollection 2025. Ther Adv Med Oncol. 2025. PMID: 40985041 Free PMC article.
72 results